J
Jeroen M.H. Hendriks
Researcher at University of Antwerp
Publications - 175
Citations - 2952
Jeroen M.H. Hendriks is an academic researcher from University of Antwerp. The author has contributed to research in topics: Isolated lung perfusion & Lung cancer. The author has an hindex of 27, co-authored 160 publications receiving 2596 citations. Previous affiliations of Jeroen M.H. Hendriks include Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Quality of life evolution after lung cancer surgery: a prospective study in 100 patients.
TL;DR: QoL evolution profiles comparing pre-operative status with deficits and changes at 1, 3, 6 and 12 months after pulmonary surgery are documented.
Journal ArticleDOI
AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis
Marc Bosiers,Patrick Peeters,O d'Archambeau,Jeroen M.H. Hendriks,Ernst Pilger,Christoph Düber,Thomas Zeller,Andreas Gussmann,Paul N.M. Lohle,Erich Minar,Dierk Scheinert,Klaus A. Hausegger,Karl-Ludwig Schulte,Jürgen Verbist,Koen Deloose,Johannes Lammer +15 more
TL;DR: Although the present study indicates that the AMS technology can be safely applied, it did not demonstrate efficacy in long-term patency over standard PTA in the infrapopliteal vessels.
Journal ArticleDOI
Quality of life after lung cancer surgery: a prospective pilot study comparing bronchial sleeve lobectomy with pneumonectomy.
TL;DR: The high burden of dyspnea, general pain, thoracic pain and shoulder dysfunction reported after pneumonectomy, is not seen after sleeve lobectomy, and in patients with anatomically appropriate early-stage lung cancer, sleeves lobectomy offers better quality of life than does pneumonectomies.
Journal ArticleDOI
The effect of smoking cessation on quality of life after lung cancer surgery.
Bram Balduyck,Peyman Sardari Nia,Anouschka Cogen,Yanina Dockx,Patrick Lauwers,Jeroen M.H. Hendriks,Paul Van Schil +6 more
TL;DR: Smoking cessation is beneficial at any time point to lung cancer surgery and current smoking at the time of surgery is associated with a poor postoperative QoL.
Journal ArticleDOI
Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
Marc Bosiers,Koen Deloose,Joren Callaert,Jürgen Verbist,Jeroen M.H. Hendriks,Patrick Lauwers,Herman Schroë,Wouter Lansink,Dierk Scheinert,Andrej Schmidt,Thomas Zeller,Ulrich Beschorner,Elias Noory,Giovanni Torsello,Martin Austermann,Patrick Peeters +15 more
TL;DR: The treatment of femoropopliteal in-stent restenosis with a Viabahn endoprosthesis showed significantly better results than treatment with a standard balloon at 1 year, and the primary effectiveness outcome was primary patency at 12 months.